Literature DB >> 10725815

Lupus erythematosus tumidus and chronic discoid lupus erythematosus in carriers of X-linked chronic granulomatous disease.

R A Rupec1, T Petropoulou, B H Belohradsky, M Walchner, J G Liese, G Plewing, G Messer.   

Abstract

Two Caucasian carriers for chronic granulomatous disease (CGD) developed cutaneous lupus erythematosus (LE) with clinically and morphologically characteristic appearance for chronic discoid lupus erythematosus (DLE) and lupus erythematosus tumidus (LET). Direct immunofluorescent examinations and ANA titers were positive in both young women. No systemic involvement due to the ACR criteria was evident. Their sons suffered from X-linked cytochrome-b negative CGD. The diagnosis of CGD was based on measurement of oxidative burst activity by nitroblue tetrazolium (NBT) slide test and by flow cytometry using dihydrorhodamine 123 (DHR). The absence of cytochrome b558 in neutrophilic granulocytes was confirmed photometrically and by flow cytometry using the 7D5 monoclonal antibody against cytochrome b. We report for the first time the association of the photosensitive LE subtype LET and the X-linked CGD carrier state. Tissue damage by UV radiation and a reduced antimicrobial capacity may lead to recurrent immune stimulation and may together with genetic predisposition explain the occurrence of cutaneous LE in female carriers of CGD.

Entities:  

Mesh:

Year:  2000        PMID: 10725815

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  12 in total

Review 1.  Chronic granulomatous disease.

Authors:  Steven M Holland
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

Review 2.  LC3-Associated Phagocytosis and Inflammation.

Authors:  Bradlee L Heckmann; Emilio Boada-Romero; Larissa D Cunha; Joelle Magne; Douglas R Green
Journal:  J Mol Biol       Date:  2017-08-25       Impact factor: 5.469

Review 3.  Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease.

Authors:  A C Battersby; A M Cale; D Goldblatt; A R Gennery
Journal:  J Clin Immunol       Date:  2013-11       Impact factor: 8.317

Review 4.  Myeloid Cell Turnover and Clearance.

Authors:  William J Janssen; Donna L Bratton; Claudia V Jakubzick; Peter M Henson
Journal:  Microbiol Spectr       Date:  2016-11

5.  Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation.

Authors:  Mary Joseph Acevedo; Jennifer S Wilder; Sharon Adams; Joie Davis; Corin Kelly; Dianne Hilligoss; Ellen Carroll; Bazetta Blacklock-Schuver; Kristen Cole; Elizabeth M Kang; Amy P Hsu; Christopher G Kanakry; Dimana Dimitrova; Jennifer A Kanakry
Journal:  Biol Blood Marrow Transplant       Date:  2019-04-12       Impact factor: 5.742

6.  Severe X-linked chronic granulomatous disease in two unrelated females.

Authors:  Sylvie Chollet-Martin; Anne Lopez; Catherine Gaud; Dominique Henry; Bertrand Stos; Jamel El Benna; Gaëlle Chedevile; Dominique Gendrel; Marie-Anne Gougerot-Pocidalo; Bernard Grandchamp; Bénédicte Gérard
Journal:  Eur J Pediatr       Date:  2006-11-03       Impact factor: 3.183

7.  PPARγ activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease.

Authors:  Ruby Fernandez-Boyanapalli; S Courtney Frasch; David W H Riches; R William Vandivier; Peter M Henson; Donna L Bratton
Journal:  Blood       Date:  2010-08-06       Impact factor: 22.113

Review 8.  Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology.

Authors:  C M Cale; L Morton; D Goldblatt
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

Review 9.  Chronic granulomatous disease.

Authors:  Steven M Holland
Journal:  Hematol Oncol Clin North Am       Date:  2012-11-22       Impact factor: 3.722

Review 10.  Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase.

Authors:  Michela G Schäppi; Vincent Jaquet; Dominique C Belli; Karl-Heinz Krause
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.